JoseIgnacioMayordomoMD

PubMed

• 3 citations
  Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer.
  Elena Shagisultanova, William Gradishar, Ursa Brown-Glaberman, Pavani Chalasani, Andrew J Brenner
  Clinical Cancer Research. 2023-12-15
• 5 citations
  Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer.
  Anthony D Elias, Nicole S Spoelstra, Alyse W Staley, Sharon Sams, Lyndsey S Crump
  NPJ Breast Cancer. 2023-05-20
• 53 citations
  Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and...
  Funda Meric-Bernstam, Muralidhar Beeram, Erika Hamilton, Do-Youn Oh, Diana L Hanna
  The Lancet. Oncology. 2022-12-01

Journal Articles

• Phase III Multicenter Clinical Trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) Vaccine for Metastatic Breast Cancer  
  Ibrahim N, Miles D, Tres A, Roche H, Guillem V, Martin M, Perren T, Cameron D, Glaspy J, Dodwell D, Parker J, Mayordomo J, and the Theratope Study Group, Oncologist, 1/1/2011
• Spanish Society of Medical Oncology consensus for the use of haematopoietic colony-stimulating factors in cancer patients  
  Carrato Mena A, Paz-Ares Rodriguez L, Rodriguez Lescure A, Casas Fernandez de Tejerina AM, Diaz Rubio Garcia E, Perez Segura P, Constenla Figueiras M, Garcia Carbonero..., Clinical and Translational Oncology, 1/1/2009
• Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain  
  Mayordomo JI, Lopez A, Vinolas N, Castellanos J, Pernas S, Domingo Alonso J, Frau A, Layola M, Antonio Gasquet J, Sanchez J; ENIA Study Group, Curr Med Res Opin, 1/1/2009
• Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor-Positive Breast Cancer  
  Baselga J, Semiglazov V, van Dam P, Manikhas A, Bellet M, Mayordomo J, Campone M, Kubista E, Greil R, Bianchi G, Steinseifer J, Molloy B, Tokaji E, Gardner H, Phillips..., Journal of Clinical Oncology, 1/1/2009
• Sequence variants at the TERT- CLPTM1L locus associate with multiple cancer types  
  Rafnar T, Sulem P, Stacey SN, Geller F, Gudmundsson J, Sigurdsson A, Jakobsdottir M, Helgadottir H, Thorlacius S, Aben KKH, Blondal T, Thorgeirsson T, Thorleifsson G, ..., Nat Genet, 1/1/2009
• Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial  
  Untch M, Gelber RD, Jackisch C, Procter M, Baselga J, Bell R, Cameron D, Gianni L, Smith I, Leyland-Jones B, de Azambuja E, Wermuth P, Khasanov R, Feng-yi F, Hartmann ..., Ann Oncol, 1/1/2008
• Common Sequence Variants in the MRPS30 Locus on Chromosome 5p12 Confer Susceptibility to Estrogen Receptor Positive Breast cancer  
  Stacey SN, Manolescu A, Sulem P, Thorlacius S, Gudjonsson SA, Jonsson GF, Jakobsdottir M, Bergthorsson JT, Gudmundsson J, Sigurosson A, Aben KK, Strobbe LJ, Albers-Akk..., Nat Genet, 1/1/2008
• Neoadjuvant anastrozole alone or with gefitinib in early breast cancer: A phase II placebo controlled trial (223) with biological and clinical outcomes  
  Smith I, Walsh G, Skene A, Llombart A, Mayordomo JI, Detre S, Salter J, Clark E, Magill P Dowsett M, J Clin Oncol, 1/1/2007
• Common Variants on Chromosomes 2q35 and 16q12 Confer Susceptibility to Estrogen Receptor Positive Breast Cancer  
  Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson SA, Masson G, Jakobsdottir M, Thorlacius S, Helgason A, Aben KK, Henderson BE, Kolonel LN, Le Marc..., Nature Genetics, 1/1/2007
• Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: A multicenter randomized trial  
  Garcia-Carbonero, R; Mayordomo JI; Tornamira, MV; Lopez-Brea, M; Rueda, A; Guillem, V; Arcediano, A; Yubero, A; Ribera, F; Gomez, C; Tres, A; Perez-Gracia, JL; Lumbrer..., Journal of the National Cancer Institute, 1/1/2001
• Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity  
  Celluzzi, CM; Mayordomo JI; Storkus, WJ; Lotze, MT; Falo, LD, Journal of Experimental Medicine, 1/1/1996
• Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines  
  Mayordomo JI; Loftus, DJ; Sakamoto, H; DeCesare, CM; Appasamy, PM; Lotze, MT; Storkus, WJ; Appella, E; DeLeo, AB, Journal of Experimental Medicine, 1/1/1996
• Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines  
  Zitvogel, L; Mayordomo JI; Tjandrawan, T; DeLeo, AB; Clarke, MR; Lotze, MT; Storkus, WJ, Journal of Experimental Medicine, 1/1/1996
• Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors  
  Mayordomo JI; Rivera F; Diaz-Puente MT; Lianes P; Colomer R; Lopez-Brea M; Lopez E; Paz-Ares L; Hitt R; Garcia Ribas I; Cubedo R; Alonso S; Cortes-Funes H, Journal of the National Cancer Institute, 1/1/1995
• Bone-marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity  
  Mayordomo JI; Zorina T; Storkus WJ; Zitvogel L; Celluzzi C; Falo LD; Melief CJ; Ilstad ST; Kast WM; De Leo AB; Lotze MT, Nature Medicine, 1/1/1995
• Join now to see all